ATEM CAPITAL FUND LP
ATEM Capital (atemcap.com) is a NY-based Life Sciences investment fund that invests in breakthrough BioPharma / MedTech / Digital Health. Our prioritized therapeutic areas are platform technologies to cure oncology, autoimmune, cardiovascular, neurology diseases, and infections. In the last years, our team had over ten successful co-investments with the leading venture firms of the US and Europe: OrbiMed, Domain Associates, Canaan, ProQuest, LSP, Aisling Capital, MPM, Alta Partners, Frazier, Sof... innova, KPCB, as well as with the corporate venture firms: Pfizer, Roche, J&JDC, Novo, etc. Prioritized therapeutic areas are oncology, autoimmune diseases, rare diseases, and neurology. Our team members have extensive hands-on experience in product launches (over 40 products in the US and Europe), investments management (over $30 billion overall investment/liquidity), and exits of venture-backed companies.
ATEM CAPITAL FUND LP
Industry:
Biotechnology Health Care Semantic Web
Founded:
2020-12-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Google Apps For Business Cloudflare JS CDN JS GoDaddy DNS
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-07 | Arpeggio Bio | ATEM Capital Fund LP investment in Series A - Arpeggio Bio | 17 M USD |
| 2022-03-17 | Triumvira Immunologics | ATEM Capital Fund LP investment in Series A - Triumvira Immunologics | 45 M USD |
| 2021-09-16 | Amolyt Pharma | ATEM Capital Fund LP investment in Series B - Amolyt Pharma | 80 M USD |
| 2021-03-16 | Iridia | ATEM Capital Fund LP investment in Series B - Iridia | 24 M USD |